Multi-Utilities(IN20308.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
Multi-Utilities
IN20308.HK
News
View More

Tianjin Development's subsidiary invests RMB 85 million to subscribe to wealth management products

TIANJIN DEV announced that last Wednesday (24th), its indirectly non-wholly-owned subsidiary Lishengpharma entered into the twelfth financial management agreement with INDUSTRIAL BANK, with a principal amount of RMB 85 million to subscribe for another structured deposit. The investment period is 182 days, with an expected annualized yield of 1.2% to 1.6%

AASTOCKS·
SH
601166
-0.93%
HK
00882
0.00%
SZ
002393
+0.45%
AASTOCKS·
SH
601166
-0.93%
HK
00882
0.00%
SZ
002393
+0.45%

Tianjin Development has been granted a term loan with a ceiling of HKD 2 billion

According to the Zhitong Finance APP, Tianjin Development announced that the company, as the borrower, has signed a financing agreement with a group of lenders (lenders) on September 17, 2025, for a term loan with a maximum limit of HKD 2 billion, with a term of 36 months from the date of drawdown

Zhitong·
HK
00882
0.00%
Zhitong·
HK
00882
0.00%

Tianjin Development's structured deposit with a subscription principal amount of 70 million yuan

According to the Zhitong Finance APP, Tianjin Development announced that on September 10, 2025, Lisheng Pharmaceutical (the company's indirectly non-wholly-owned subsidiary) entered into the 10th wealth management agreement with INDUSTRIAL BANK, with a principal amount of RMB 70 million (equivalent to approximately HKD 76.5864 million) to subscribe for another structured deposit

Zhitong·
HK
00882
0.00%
SH
601166
-0.93%
Zhitong·
HK
00882
0.00%
SH
601166
-0.93%

TIANJIN DEV released its interim results, with profit attributable to shareholders of HKD 344 million, an increase of 19.57% year-on-year

According to the Zhitong Finance APP, TIANJIN DEV announced its interim results for the six months ending June 30, 2025, with revenue of HKD 1.719 billion, a year-on-year decrease of 5.59%; profit attributable to shareholders of HKD 344 million, a year-on-year increase of 19.57%; basic earnings per share of HKD 0.3211; and a proposed interim dividend of HKD 0.0518 per share

Zhitong·
HK
00882
0.00%
Zhitong·
HK
00882
0.00%

Tianjin Development's subsidiary subscribes to a financial product worth 50 million yuan

According to the Zhitong Finance APP, Tianjin Development announced that on June 19, 2025, Lifeng Pharmaceutical (an indirectly non-wholly-owned subsidiary of the company) entered into the ninth wealth management agreement with Xingyin Wealth Management and Industrial Bank, subscribing to another fixed-income investment product with a principal amount of RMB 50 million

Zhitong·
HK
00882
0.00%
Zhitong·
HK
00882
0.00%
© 2026 Longbridge｜Disclaimer